Wells Fargo Maintains Equal-Weight on StoneCo, Lowers Price Target to $9
Wells Fargo analyst Jeff Cantwell maintains StoneCo (NASDAQ:STNE) with a Equal-Weight and lowers the price target from $10 to $9.
Goldman Sachs Downgrades StoneCo to Sell, Lowers Price Target to $7.8
Goldman Sachs analyst Tito Labarta downgrades StoneCo (NASDAQ:STNE) from Neutral to Sell and lowers the price target from $9.8 to $7.8.
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday’s Mid-Day Session
Gainers
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.
Bed Bath & Beyond, StoneCo And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session
Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 41.1% to $10.92 in pre-market trading after a new SEC filing confirmed that GameStop chair Ryan Cohen sold his stake in the home furnishings retailer.
Earnings Scheduled For August 18, 2022
Companies Reporting Before The Bell
• Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.